I am a Physician who has a special interest in the diagnosis and management of Osteoporosis. I welcome your comments/feedback. Please feel free to contribute to this WebLog. Or alternatively you can visit www.osteoporosis-advisor.com
Note: The contents of this blog are for informational purposes only and should not be construed as medical advice or substitute for professional care.
PLEASE CHECK OUR NEW SITE AT WWW.BONESENSE.COM
Visit Osteoporosis Advisor
Monthly 2-Dose Regimen Approved for Risedronate (Actonel) in Postmenopausal Osteoporosis
Posted on June 14, 2007
On April 16, the FDA approved a new dose regimen for risedronate sodium tablets (Actonel, Proctor & Gamble Pharmaceuticals Inc) allowing patients the option of taking a 75-mg tablet on 2 consecutive days each month for the prevention and treatment of postmenopausal osteoporosis.The convenience of a monthly 2-day dose may appeal to patients taking a daily 5-mg dose or weekly 35-mg dose, the company said in a news release.Approval of the 2-day monthly regimen was based on data from an active-controlled double-blind study(n = 1229), which showed that its use yielded similar increases from baselin...
Original article link
Subscribe to Osteoporosis Advisor